JP2002504085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002504085A5 JP2002504085A5 JP1997538988A JP53898897A JP2002504085A5 JP 2002504085 A5 JP2002504085 A5 JP 2002504085A5 JP 1997538988 A JP1997538988 A JP 1997538988A JP 53898897 A JP53898897 A JP 53898897A JP 2002504085 A5 JP2002504085 A5 JP 2002504085A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1704996P | 1996-04-26 | 1996-04-26 | |
| US60/017,049 | 1996-04-26 | ||
| GBGB9610192.8A GB9610192D0 (en) | 1996-05-15 | 1996-05-15 | DNA vaccine formulations |
| US84452597A | 1997-04-18 | 1997-04-18 | |
| US9610192.8 | 1997-04-18 | ||
| US08/844,525 | 1997-04-18 | ||
| PCT/US1997/006655 WO1997040839A1 (en) | 1996-04-26 | 1997-04-22 | Dna vaccine formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002504085A JP2002504085A (ja) | 2002-02-05 |
| JP2002504085A5 true JP2002504085A5 (ja) | 2004-12-09 |
| JP4386965B2 JP4386965B2 (ja) | 2009-12-16 |
Family
ID=27268281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53898897A Expired - Fee Related JP4386965B2 (ja) | 1996-04-26 | 1997-04-22 | Ｄｎａワクチン製剤 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0906110B1 (ja) |
| JP (1) | JP4386965B2 (ja) |
| AT (1) | ATE285239T1 (ja) |
| AU (1) | AU727306B2 (ja) |
| CA (1) | CA2252565C (ja) |
| DE (1) | DE69732029T2 (ja) |
| ES (1) | ES2234018T3 (ja) |
| WO (1) | WO1997040839A1 (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387695B1 (en) | 1997-12-23 | 2002-05-14 | Merck & Co., Inc. | DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| DE69925113T2 (de) * | 1998-03-13 | 2006-01-19 | Wyeth | Polynukleotidzusammensetzung, verfahren zu deren herstellung und verwendung |
| US7276359B1 (en) | 1998-03-13 | 2007-10-02 | Wyeth | Polynucleotide composition, method of preparation, and use thereof |
| EP1555033A3 (en) * | 1998-03-13 | 2005-08-17 | Wyeth | Polynucleotide composition, method of preparation, and use thereof |
| US6818626B1 (en) * | 1998-07-17 | 2004-11-16 | Mirus Corporation | Chelating systems for use in the delivery of compounds to cells |
| JP2001316297A (ja) * | 2000-02-23 | 2001-11-13 | Kaken Pharmaceut Co Ltd | 遺伝子包埋リポソーム製剤及びその製法 |
| AU4346101A (en) * | 2000-03-07 | 2001-09-17 | Merck & Co., Inc. | Adenovirus formulations |
| AU2002366809A1 (en) | 2001-12-20 | 2003-07-09 | Schering-Plough Corporation | Syn3 compositions and methods |
| ATE357219T1 (de) * | 2002-01-25 | 2007-04-15 | Glaxo Group Ltd | Darreichungsformen für dns |
| GB0201736D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | DNA dosage forms |
| AU2003218168A1 (en) * | 2002-03-15 | 2003-09-29 | University Of Southern California | Ophthalmic solutions for delivery of expression vectors |
| BR0314751A (pt) | 2002-09-27 | 2005-07-26 | Powderject Res Ltd | Partìculas adequadas para suprimento a partir de um dispositivo de suprimento, receptáculo de dosagem para um dispositivo de suprimento, dispositivo de suprimento mediado por partìcula, processo para a preparação de partìculas adequadas para suprimento a partir de um dispositivo de suprimento, e, métodos de imunização por ácido nucleico e de terapia genética |
| GB2395950A (en) * | 2002-12-06 | 2004-06-09 | Hong Kong Dna Chips Ltd | A method for extracting, purifying and preserving genetic material |
| WO2004060059A2 (en) | 2002-12-23 | 2004-07-22 | Vical Incorporated | Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
| WO2004060363A1 (en) | 2002-12-23 | 2004-07-22 | Vical Incorporated | Method for producing sterile polynucleotide based medicaments |
| JP2011507816A (ja) * | 2007-12-21 | 2011-03-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | マラリア用ワクチン |
| RU2723032C2 (ru) * | 2014-12-29 | 2020-06-08 | Бонак Корпорейшн | Композиция, стабильно содержащая молекулу нуклеиновой кислоты |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
| WO1993003167A1 (en) * | 1991-08-06 | 1993-02-18 | The World Health Organisation | Method of isolation of dna |
| US5811406A (en) * | 1995-06-07 | 1998-09-22 | Regents Of The University Of California | Dry powder formulations of polynucleotide complexes |
| EP0849992B1 (en) * | 1995-06-07 | 2004-08-25 | WHATMAN plc | Dry solid medium for storage and analysis of genetic material |
-
1997
- 1997-04-22 AU AU29242/97A patent/AU727306B2/en not_active Ceased
- 1997-04-22 ES ES97923435T patent/ES2234018T3/es not_active Expired - Lifetime
- 1997-04-22 DE DE69732029T patent/DE69732029T2/de not_active Expired - Lifetime
- 1997-04-22 JP JP53898897A patent/JP4386965B2/ja not_active Expired - Fee Related
- 1997-04-22 WO PCT/US1997/006655 patent/WO1997040839A1/en active IP Right Grant
- 1997-04-22 AT AT97923435T patent/ATE285239T1/de not_active IP Right Cessation
- 1997-04-22 CA CA2252565A patent/CA2252565C/en not_active Expired - Fee Related
- 1997-04-22 EP EP97923435A patent/EP0906110B1/en not_active Expired - Lifetime